T1 Intervention 1489 1498 liposomes
T2 Biomarker 416 422 CPD100
T3 Biomarker 182 188 CPD100
T4 Biomarker 1236 1242 CPD100
T5 Biomarker 1285 1291 CPD100
T6 Condition 602 633 A549 non-small lung cancer cell
T7 Biomarker 348 354 CPD100
T8 Biomarker 785 791 CPD100
T9 Biomarker 372 385 sphingomyelin
T10 Condition 1535 1549 A549 xenograft
T11 Biomarker 372 398 sphingomyelin/cholesterol 
T12 Biomarker 676 682 CPD100
T13 Condition 1607 1612 tumor
T14 Disease 744 752 toxicity
T15 Species 1559 1563 mice
T16 Level 635 649 A549 cell line
T17 Biomarker 169 180 vinblastine
T18 Biomarker 386 397 cholesterol
T19 Intervention 1766 1771 blood
T20 Disease 2008 2016 toxicity
T21 Intervention 1396 1405 liposomes
T22 Intervention 1574 1583 liposomes
T23 Biomarker 466 477 cholesterol
T24 Biomarker 502 508 CPD100
T25 Biomarker 452 465 sphingomyelin
T26 Intervention 1701 1706 blood
T27 Biomarker 562 568 CPD100
T28 Species 844 849 mouse
T29 Intervention 1657 1662 blood
T30 Biomarker 1236 1245 CPD100 Li
T31 Biomarker 258 264 oxygen
T32 Biomarker 452 482 sphingomyelin/cholesterol/PEG 
T33 Condition 6 11 tumor
